Relationship Between Metabolic Toxicity and Efficacy of Everolimus in Patients With Neuroendocrine Tumors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Relationship Between Metabolic Toxicity and Efficacy of Everolimus in Patients With Neuroendocrine Tumors: A Pooled Analysis From the Randomized, Phase 3 RADIANT-3 and RADIANT-4 Trials
Cancer 2021 Apr 15;[EPub Ahead of Print], N Fazio, C Carnaghi, R Buzzoni, JW Valle, F Herbst, A Ridolfi, J Strosberg, MH Kulke, ME Pavel, JC YaoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.